
|Videos|May 2, 2022
A discourse in clinical study timelines and the need for acceleration in retina research
Author(s)David Hutton, Emily Kaiser Maharjan
Dr. David Bingaman of Ora Clinical discusses today’s need to accelerate clinical studies and increase investments in retina and challenging disease states.
Advertisement
David Hutton, executive editor of Ophthalmology Times®, sits down with David Bingaman, DVM, PhD, Chief Development Officer of Ora Clinical to discuss the need to accelerate clinical trials and increase investments in retina research. Dr. Bingaman also discusses Ora Clinical’s presence at ARVO 2022.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
Eichenbaum Acorns: From clinic to C-suite with Jay S. Duker, MD, and Ramiro Ribeiro, MD, PhD
2
Altered ipRGC circuits and function may translate to disrupted sleep and circadian rhythms in Alzheimer’s disease
3
StemSight gains patent for off-the-shelf limbal stem cell platform patent milestone for STE-101
4




















